GILLA KAPLAN - 31 Dec 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Christopher R. Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 15:23:24 UTC
Previous filing
04 Oct 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +12,767 $0.000000 12,767 31 Dec 2021 Common Stock 12,767 $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of this stock option will immediately vest on the date that it is granted.